Advertisement
Screener

UFP Technologies, Inc. (UFPT) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

UFP Technologies, Inc. Operating Cash Flow

UFP Technologies, Inc. (UFPT) reported Operating Cash Flow of $18.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06

  • UFP Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $15.61M, a 38.37% decline year-over-year.
  • UFP Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $3.20M, a 76.80% decline year-over-year.
  • UFP Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $16.84M, a 31.06% decline year-over-year.
  • UFP Technologies, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $35.92M, a 81.43% increase year-over-year.
  • UFP Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $91.91M, a 38.01% increase from fiscal 2024.
  • UFP Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $66.59M, a 61.11% increase from fiscal 2023.
  • UFP Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $41.33M, a 132.95% increase from fiscal 2022.
  • UFP Technologies, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $17.74M, a 24.14% increase from fiscal 2021.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 month
2026-06-30$15.61M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$18.82M
10-Q · filed 2026-08-06
$35.66M
derived: sum of 3 quarters · filed 2026-08-06
$71.58M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$3.20M
10-Q · filed 2026-05-08
$20.04M
derived: sum of 2 quarters · filed 2026-05-08
$55.97M
derived: sum of 3 quarters · filed 2026-05-08
$81.30M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$16.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$52.76M
derived: sum of 2 quarters · filed 2026-02-27
$78.09M
derived: sum of 3 quarters · filed 2026-08-06
$91.91M
10-K · filed 2026-02-27
2025-09-30$35.92M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$61.26M
derived: sum of 2 quarters · filed 2026-08-06
$75.07M
10-Q · filed 2025-11-07
$99.49M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$25.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$39.14M
10-Q · filed 2026-08-06
$63.56M
derived: sum of 3 quarters · filed 2026-08-06
$83.37M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$13.81M
10-Q · filed 2026-05-08
$38.23M
derived: sum of 2 quarters · filed 2026-05-08
$58.03M
derived: sum of 3 quarters · filed 2026-05-08
$69.75M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$24.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$44.23M
derived: sum of 2 quarters · filed 2026-02-27
$55.94M
derived: sum of 3 quarters · filed 2026-02-27
$66.59M
10-K · filed 2026-02-27
2024-09-30$19.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$31.52M
derived: sum of 2 quarters · filed 2025-11-07
$42.17M
10-Q · filed 2025-11-07
$54.87M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$11.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$22.37M
10-Q · filed 2025-08-11
$35.07M
derived: sum of 3 quarters · filed 2026-02-27
$53.10M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$10.65M
10-Q · filed 2025-05-12
$23.36M
derived: sum of 2 quarters · filed 2026-02-27
$41.39M
derived: sum of 3 quarters · filed 2026-02-27
$50.27M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$12.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$30.73M
derived: sum of 2 quarters · filed 2026-02-27
$39.61M
derived: sum of 3 quarters · filed 2026-02-27
$41.33M
10-K · filed 2026-02-27
2023-09-30$18.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$26.91M
derived: sum of 2 quarters · filed 2024-11-12
$28.63M
10-Q · filed 2024-11-12
$46.52M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30$8.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$10.60M
10-Q · filed 2024-08-09
$28.49M
derived: sum of 3 quarters · filed 2025-03-03
$28.38M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$1.72M
10-Q · filed 2024-05-10
$19.61M
derived: sum of 2 quarters · filed 2025-03-03
$19.50M
derived: sum of 3 quarters · filed 2025-03-03
$22.68M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31$17.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
$17.78M
derived: sum of 2 quarters · filed 2025-03-03
$20.96M
derived: sum of 3 quarters · filed 2025-03-03
$17.74M
10-K · filed 2025-03-03
2022-09-30-$109.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$3.07M
derived: sum of 2 quarters · filed 2023-11-09
-$144.00K
10-Q · filed 2023-11-09
$472.00K
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$3.18M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$35.00K
10-Q · filed 2023-08-09
$581.00K
derived: sum of 3 quarters · filed 2024-02-29
$4.37M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31-$3.22M
10-Q · filed 2023-05-10
-$2.60M
derived: sum of 2 quarters · filed 2024-02-29
$1.19M
derived: sum of 3 quarters · filed 2024-02-29
$7.74M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$616.00K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-02-29
$4.41M
derived: sum of 2 quarters · filed 2024-02-29
$10.96M
derived: sum of 3 quarters · filed 2024-02-29
$14.29M
10-K · filed 2024-02-29
2021-09-30$3.79M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14
$10.34M
derived: sum of 2 quarters · filed 2022-11-14
$13.68M
10-Q/A · filed 2022-11-14
$13.68M
10-Q · filed 2021-11-05
$21.98M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$6.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$9.89M
10-Q · filed 2022-08-09
$18.19M
derived: sum of 3 quarters · filed 2023-03-16
$24.19M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31$3.33M
10-Q · filed 2022-05-10
$11.63M
derived: sum of 2 quarters · filed 2023-03-16
$17.64M
derived: sum of 3 quarters · filed 2023-03-16
$23.63M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31$8.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$14.30M
derived: sum of 2 quarters · filed 2023-03-16
$20.30M
derived: sum of 3 quarters · filed 2023-03-16
$25.04M
10-K · filed 2023-03-16
2020-09-30$6.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$12.00M
derived: sum of 2 quarters · filed 2021-11-05
$16.74M
10-Q · filed 2021-11-05
$25.58M
derived: sum of 4 quarters · filed 2022-03-14
2020-06-30$5.99M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$10.74M
10-Q · filed 2021-08-06
$19.58M
derived: sum of 3 quarters · filed 2022-03-14
$29.61M
derived: sum of 4 quarters · filed 2022-03-14
2020-03-31$4.74M
10-Q · filed 2021-05-07
$13.59M
derived: sum of 2 quarters · filed 2022-03-14
$23.61M
derived: sum of 3 quarters · filed 2022-03-14
$32.34M
derived: sum of 4 quarters · filed 2022-03-14
2019-12-31$8.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
$18.87M
derived: sum of 2 quarters · filed 2022-03-14
$27.60M
derived: sum of 3 quarters · filed 2022-03-14
$31.23M
10-K · filed 2022-03-14
2019-09-30$10.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$18.76M
derived: sum of 2 quarters · filed 2020-11-06
$22.39M
10-Q · filed 2020-11-06
$30.16M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30$8.73M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$12.36M
10-Q · filed 2020-08-07
$20.13M
derived: sum of 3 quarters · filed 2021-03-12
$26.23M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31$3.63M
10-Q · filed 2020-05-08
$11.40M
derived: sum of 2 quarters · filed 2021-03-12
$17.50M
derived: sum of 3 quarters · filed 2021-03-12
$26.94M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31$7.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$13.87M
derived: sum of 2 quarters · filed 2021-03-12
$23.31M
derived: sum of 3 quarters · filed 2021-03-12
$21.32M
10-K · filed 2021-03-12
2018-09-30$6.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$15.54M
derived: sum of 2 quarters · filed 2019-11-08
$13.55M
10-Q · filed 2019-11-08
$18.01M
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30$9.44M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$7.45M
10-Q · filed 2019-08-09
$11.91M
derived: sum of 3 quarters · filed 2020-03-13
$16.99M
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31-$1.99M
10-Q · filed 2019-05-10
$2.47M
derived: sum of 2 quarters · filed 2020-03-13
$7.55M
derived: sum of 3 quarters · filed 2020-03-13
$11.34M
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31$4.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$9.54M
derived: sum of 2 quarters · filed 2020-03-13
$13.33M
derived: sum of 3 quarters · filed 2020-03-13
$17.47M
10-K · filed 2020-03-13
2017-09-30$5.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$8.87M
derived: sum of 2 quarters · filed 2018-11-09
$13.01M
10-Q · filed 2018-11-09
$16.05M
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30$3.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$7.93M
10-Q · filed 2018-08-09
$10.96M
derived: sum of 3 quarters · filed 2019-03-15
2017-03-31$4.14M
10-Q · filed 2018-05-10
$7.18M
derived: sum of 2 quarters · filed 2019-03-15
2016-12-31$3.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$9.31M
10-K · filed 2019-03-15
2016-09-30$6.27M
10-Q · filed 2017-11-09
2015-12-31$12.52M
10-K · filed 2018-03-16
2011-06-30$4.98M
10-Q · filed 2011-08-10
2010-06-30$5.03M
10-Q · filed 2011-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
AtriCure, Inc. (ATRC)United States$3.089B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57